Ben Berkhout studied molecular biology at Leiden University, and he obtained the Ph.D. degree in 1986 on a research project concerning the regulation of translation by means of RNA structure in RNA bacteriophages. He performed postdoctoral research at the Dana Farber Cancer Institute of the Harvard Medical School in the field of molecular immunology, and he initiated HIV-1 research at the National Institutes of Health in Bethesda. He initiated a molecular virology research line in 1991 upon his return to the Netherlands, and he has been at the University of Amsterdam since then. He became Head of the Laboratory of Experimental Virology and was appointed as a Full Professor in 2002. He serves as an Editor for the Journal of Biomedical Science, Retrovirology, Journal of General Virology and as an Associate Editor for several journals (Nucleic Acids Research, Journal of Virology, Biotechnology, Current HIV Research, Journal of Biological Chemistry, Journal of RNAi and Gene Silencing, RNA biology, etc.). He has published over 300 peer-reviewed manuscripts on diverse topics concerning HIV-1 replication (mechanism of transcription, reverse transcription, RNA-regulated functions), virus evolution (both as a research tool and the underlying molecular mechanisms of drug-resistance), virus discovery (human coronavirus NL63), new antiviral therapeutic strategies (RNA interference), and HIV-1 vaccine design.
Biography Updated on 2 December 2010